CD8α+ dendritic cells prime TCR‐peptide‐reactive regulatory CD4+FOXP3− T cells |
| |
Authors: | Trevor R. F. Smith Igor Maricic Francesco Ria Susan Schneider Vipin Kumar |
| |
Affiliation: | 1. Laboratory of Autoimmunity, Torrey Pines Institute for Molecular Studies, San Diego, CA, USA;2. La Jolla Institute for Allergy and Immunology, San Diego, CA, USA |
| |
Abstract: | CD4+ T cells with immune regulatory function can be either FOXP3+ or FOXP3?. We have previously shown that priming of naturally occurring TCR‐peptide‐reactive CD4+FOXP3? Treg specifically controls Vβ8.2+CD4+ T cells mediating EAE. However, the mechanism by which these Treg are primed to recognize their cognate antigenic determinant, which is derived from the TCRVβ8.2‐chain, is not known. In this study we show that APC derived from splenocytes of naïve mice are able to stimulate cloned CD4+ Treg in the absence of exogenous antigen, and their stimulation capacity is augmented during EAE. Among the APC populations, DC were the most efficient in stimulating the Treg. Stimulation of CD4+ Treg was dependent upon processing and presentation of TCR peptides from ingested Vβ8.2TCR+CD4+ T cells. Additionally, DC pulsed with TCR peptide or apoptotic Vβ8.2+ T cells were able to prime Treg in vivo and mediate protection from disease in a CD8‐dependent fashion. These data highlight a novel mechanism for the priming of CD4+ Treg by CD8α+ DC and suggest a pathway that can be exploited to prime antigen‐specific regulation of T‐cell‐mediated inflammatory disease. |
| |
Keywords: | Antigen presentation/processing DC EAE/MS TCR Tolerance/suppression/anergy |
|
|